Document Detail

Effect of stroke on arginase expression and localization in the rat brain.
MedLine Citation:
PMID:  23311438     Owner:  NLM     Status:  Publisher    
Because arginase and nitric oxide (NO) synthases (NOS) compete to degrade l-arginine, arginase plays a crucial role in the modulation of NO production. Moreover, the arginase 1 isoform is a marker of M2 phenotype macrophages that play a key role in tissue remodeling and resolution of inflammation. While NO has been extensively investigated in ischemic stroke, the effect of stroke on the arginase pathway is unknown. The present study focuses on arginase expression/activity and localization before and after (1, 8, 15 and 30 days) the photothrombotic ischemic stroke model. This model results in a cortical lesion that reaches maximal volume at day 1 post-stroke and then decreases as a result of astrocytic scar formation. Before stroke, arginase 1 and 2 expressions were restricted to neurons. Stroke resulted in up-regulation of arginase 1 and increased arginase activity in the region centered on the lesion where inflammatory cells are present. These changes were associated with an early and long-lasting arginase 1 up-regulation in activated macrophages and astrocytes and a delayed arginase 1 down-regulation in neurons at the vicinity of the lesion. A linear positive correlation was observed between expressions of arginase 1 and glial fibrillary acidic protein as a marker of activated astrocytes. Moreover, the pattern of arginase 1 and brain-derived neurotrophic factor (BDNF) expressions in activated astrocytes was similar. Unlike arginase 1, arginase 2 expression was not changed by stroke. In conclusion, increased arginase 1 expression is not restricted to macrophages in inflammation elicited by stroke but also occurs in activated astrocytes where it may contribute to neuroplasticity through the control of BDNF production.
Aurore Quirié; Céline Demougeot; Nathalie Bertrand; Claude Mossiat; Philippe Garnier; Christine Marie; Anne Prigent-Tessier
Related Documents :
18682458 - Molecular mechanisms of corticosteroid resistance.
9307298 - Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin d3 is accompani...
7769088 - Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action...
6135698 - Development of tyrosine aminotransferase in perinatal rat liver: changes in functional ...
10679188 - Regulation of beta-catenin signaling in the wnt pathway.
8645618 - New insights in the molecular mechanism of progestin-induced proliferation of mammary e...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-13
Journal Detail:
Title:  The European journal of neuroscience     Volume:  -     ISSN:  1460-9568     ISO Abbreviation:  Eur. J. Neurosci.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8918110     Medline TA:  Eur J Neurosci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.
Faculté de Pharmacie, Unité INSERM U1093 Cognition, Action et Plasticité Sensorimotrice, Dijon, France; Université de Bourgogne, Dijon, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Detection of Early Left Ventricular and Atrial Dysfunction in Overweight Patients with Preserved Eje...
Next Document:  Safety of off-label stroke treatment with tissue plasminogen activator.